Market Overview

UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on West Pharmaceutical Services

Share:
Related WST
Benzinga's Top Upgrades, Downgrades For October 3, 2017
Benzinga's Top Upgrades, Downgrades For September 15, 2017

In a report published Monday, Jefferies & Company reiterated its Hold rating on West Pharmaceutical Services (NYSE: WST), and raised its price target from $45.00 to $49.00.

Jefferies noted, “WST continues to see progress in shifting customers to high value (and higher margin) packaging products. The company has also benefited from accelerated demand from clients, who are building inventory and launching new products. We expected that to moderate sooner than now, but still expect it to diminish in the future. We are raising EPS based on the recent performance, while maintaining future growth rates.”

West Pharmaceutical Services closed on Friday at $52.66.

Latest Ratings for WST

DateFirmActionFromTo
Oct 2017Wells FargoMaintainsOutperform
Oct 2017Bank of AmericaDowngradesBuyNeutral
Oct 2017Stephens & Co.Initiates Coverage OnEqual-Weight

View More Analyst Ratings for WST
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (WST)

View Comments and Join the Discussion!